Eargo Inc. (EAR): Price and Financial Metrics
EAR Price/Volume Stats
| Current price | $2.18 | 52-week high | $25.20 |
| Prev. close | $2.14 | 52-week low | $2.11 |
| Day low | $2.17 | Volume | 1,691 |
| Day high | $2.18 | Avg. volume | 55,037 |
| 50-day MA | $3.08 | Dividend yield | N/A |
| 200-day MA | $6.03 | Market Cap | 45.24M |
EAR Stock Price Chart Interactive Chart >
EAR POWR Grades
- EAR scores best on the Sentiment dimension, with a Sentiment rank ahead of 87.2% of US stocks.
- The strongest trend for EAR is in Growth, which has been heading down over the past 127 days.
- EAR ranks lowest in Quality; there it ranks in the 3rd percentile.
EAR Stock Summary
- With a year-over-year growth in debt of -93.22%, EARGO INC's debt growth rate surpasses just 1.17% of about US stocks.
- As for revenue growth, note that EAR's revenue has grown 1,027.45% over the past 12 months; that beats the revenue growth of 99.21% of US companies in our set.
- The volatility of EARGO INC's share price is greater than that of 94.12% US stocks with at least 200 days of trading history.
- If you're looking for stocks that are quantitatively similar to EARGO INC, a group of peers worth examining would be PLAB, SGHT, ASPN, OMCL, and HEAR.
- EAR's SEC filings can be seen here. And to visit EARGO INC's official web site, go to eargo.com.
EAR Valuation Summary
- EAR's EV/EBIT ratio is 0.1; this is 99.14% lower than that of the median Healthcare stock.
- EAR's price/sales ratio has moved down 35 over the prior 36 months.
Below are key valuation metrics over time for EAR.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| EAR | 2023-09-22 | 1.1 | 0.8 | -0.3 | 0.1 |
| EAR | 2023-09-21 | 1.1 | 0.8 | -0.3 | 0.1 |
| EAR | 2023-09-20 | 1.2 | 0.8 | -0.4 | 0.0 |
| EAR | 2023-09-19 | 1.2 | 0.8 | -0.3 | 0.0 |
| EAR | 2023-09-18 | 1.2 | 0.8 | -0.3 | 0.0 |
| EAR | 2023-09-15 | 1.2 | 0.8 | -0.4 | 0.0 |
EAR's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- EAR has a Quality Grade of D, ranking ahead of 9.8% of graded US stocks.
- EAR's asset turnover comes in at 0.45 -- ranking 106th of 186 Medical Equipment stocks.
- 500 - Internal server error
The table below shows EAR's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-06-30 | 0.450 | 0.710 | -3.415 |
| 2020-12-31 | 0.532 | 0.684 | -4.861 |
EAR Price Target
For more insight on analysts targets of EAR, see our EAR price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $55.33 | Average Broker Recommendation | 2 (Hold) |
Eargo Inc. (EAR) Company Bio
Eargo, Inc. develops next generation hearing aids and headsets solutions. It offers Eargomax, a new chip for maximum audio fidelity and noise reduction and Eargoplus a superior hearing technology designed for first time hearing aid users. The company was founded by Florent Michel, Raphael Michel and Daniel Shen on November 12, 2010 and is headquartered in San Jose, CA.
Latest EAR News From Around the Web
Below are the latest news stories about EARGO INC that investors may wish to consider to help them evaluate EAR as an investment opportunity.
Eargo Reports Second Quarter 2023 Financial ResultsRecent Highlights: Net revenues of $8.1 million in the second quarter of 2023, up 12% year-over-yearGross systems shipped of 5,098, up 14% year-over-yearGAAP total operating loss $25.8 million in the second quarter of 2023, compared to $31.4 million in the second quarter of 2022In connection with the implementation of the announced cost reduction plan, the Company expects to extend net operating cash runway into the second half of 2024 SAN JOSE, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Eargo, I |
Q1 2023 Eargo Inc Earnings CallQ1 2023 Eargo Inc Earnings Call |
Eargo Reports First Quarter 2023 Financial ResultsRecent Highlights: Net revenues of $11.8 million in the first quarter of 2023, up 29% year-over-yearGross systems shipped of 8,705, up 51% year-over-yearGAAP total operating loss $22.8 million in the first quarter of 2023, compared to $30.4 million in the first quarter of 2022Commercially launched Eargo 7, a self-fitting hearing aid with the use of Sound Match via our mobile app, in February 2023Company expects modest sequential improvements to net operating cash burn in the remaining quarters o |
Eargo to Report First Quarter 2023 Financial Results on May 11, 2023SAN JOSE, Calif., May 04, 2023 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve hearing health, today announced it will release financial results for the first quarter 2023 after market close on May 11, 2023. On the same day, Eargo will host a conference call and webcast at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to discuss its financial results and recent highlights. Interested parties may access the live call via telephone by dialing (800) |
Eargo, Inc. (NASDAQ:EAR) Q4 2022 Earnings Call TranscriptEargo, Inc. (NASDAQ:EAR) Q4 2022 Earnings Call Transcript March 23, 2023 Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Eargo, Inc. Fourth Quarter 2022 Earnings Conference Call. I would now like to turn the call over to Nick Laudico, Chief Retail Officer. Please go ahead. Nick Laudico: Good afternoon, everyone, […] |
EAR Price Returns
| 1-mo | -21.86% |
| 3-mo | -55.78% |
| 6-mo | -53.42% |
| 1-year | -90.44% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -81.04% |
| 2022 | -88.73% |
| 2021 | -88.62% |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
Loading social stream, please wait...